← Leaderboards
Eva Morava-Kozicz
Mayo Clinic Rochester
$3,129,804
Attributed
$4,100,732
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,565,429 · 9
By mechanism
U54$10,670,205 · 5
P01$1,390,367 · 2
R01$1,310,999 · 1
T32$193,858 · 1
Top collaborators
- Sihem Boudina2 shared
- Kent Lai2 shared
- Laszlo Tamas Kozicz1 shared
- Richard Steet1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Laszlo Tamas Kozicz$1,534,422
- Sean Joseph Pittock$1,682,764
- Christina Lam$1,639,127
- Surendra Dasari$464,470
- Ian R Lanza$12,553,585
Others in their field
Other Emerging Leaders on “Congenital Disorders Of Glycosylation”
- Jane Caroline Khoury · Cincinnati Childrens Hosp Med Ctr$2,637,022
- Christina Lam · Mayo Clinic Rochester$1,639,127
- Li Lei · Temple Univ Of The Commonwealth$1,313,212
- Laszlo Tamas Kozicz · Mayo Clinic Rochester$1,183,993
- Jeffrey Sorelle · Ut Southwestern Medical Center$1,170,200
- Gabriel E Haller · Washington University$679,452
Research focus
Congenital Disorders Of GlycosylationFrontierQuality Of LifeProteinsDefectGlycosylationResearch PersonnelOralSymptomsSupplementationMetabolicGalactoseLinkSymposiumDiagnosticSuccessClinical TrialsResearch DesignDietary InterventionCaringPhysiciansData CollectionClinical ResearchClinical Practice
Grant awards (21)
Investigation of Neural Pathogenic Mechanisms Associated with Congenital Disorders of Glycosylation$1,270,237
P01 · FY2025 · NS · contact PI
Pathobiological mechanisms of cardiac disease in PGM1-CDG$651,868
R01 · FY2025 · HL
T32 training grant in medical genetics.$193,858
T32 · FY2025 · GM · contact PI
Investigation of Neural Pathogenic Mechanisms Associated with Congenital Disorders of Glycosylation$120,130
P01 · FY2025 · NS · contact PI
Pathobiological mechanisms of cardiac disease in PGM1-CDG$659,131
R01 · FY2024 · HL
Frontiers in Congenital Disorders of Glycosylation$807,074
U54 · FY2023 · NS · contact PI
Frontiers in Congenital Disorders of Glycosylation$785,788
U54 · FY2023 · NS · contact PI
Admin Core$268,674
U54 · FY2023 · NS · contact PI
Clinical Trials Project$184,271
U54 · FY2023 · NS · contact PI
Frontiers in Congenital Disorders of Glycosylation$1,555,648
U54 · FY2022 · NS · contact PI
Clinical Trials Project$291,836
U54 · FY2022 · NS · contact PI
Admin Core$248,257
U54 · FY2022 · NS · contact PI
Frontiers in Congenital Disorders of Glycosylation$1,536,315
U54 · FY2021 · NS · contact PI
Clinical Trials Project$259,881
U54 · FY2021 · NS · contact PI
Admin Core$216,491
U54 · FY2021 · NS · contact PI
Frontiers in Congenital Disorders of Glycosylation$1,704,563
U54 · FY2020 · NS · contact PI
Admin Core$332,274
U54 · FY2020 · NS · contact PI
Clinical Trials Project$190,296
U54 · FY2020 · NS · contact PI
Frontiers in Congenital Disorders of Glycosylation$1,805,072
U54 · FY2019 · NS · contact PI
Admin Core$384,163
U54 · FY2019 · NS · contact PI
Clinical Trials Project$99,602
U54 · FY2019 · NS · contact PI